FdaApplication

BLA 125547

Back to search

Identifiers

Properties

PropertyValue
applicant_nameEli Lilly and Company
application_typeBLA
approval_date2015-11-24

Products (1)

ProductActive ingredientStrengthDosage form
PORTRAZZANECITUMUMAB800MG/50ML (16MG/ML)Injection

1 product